Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune DisordersDouglas B. Johnson, Joseph I. Clark, Howard L. Kaufman et al.|JAMA Oncology|2015Cited by 656
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapyWei Yen Chan, Helen Rizos, Jenny Lee et al.|Journal of Experimental & Clinical Cancer Research|2024Cited by 22
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry studyLauren Brown, Benjamin Y. Kong, Victor Khou et al.|Frontiers in Oncology|2024Cited by 6
Use of early circulating tumour DNA dynamics in patients with stage III melanoma receiving neoadjuvant combination immunotherapy.Wei Yen Chan, Helen Rizos, Jenny Lee et al.|Journal of Clinical Oncology|2024Cited by 2
Abstract B044: Fragmentomic features of cell-free DNA predict late-stage melanoma treatment benefit and survivalAaron B. Beasley, Elin S. Gray, Leslie Calapre et al.|Clinical Cancer Research|2024Cited by 0